Aclaris Therapeutics, Inc. (ACRS)
NASDAQ·Healthcare·Biotechnology
$5.13
-3.85%
Mkt Cap $660.86M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$10.60
Range $10.00 – $12.00
Implied Upside
+106.8%
Consensus $10.60 vs current $5.13
NASDAQ·Healthcare·Biotechnology
$5.13
-3.85%
Mkt Cap $660.86M
Buy
4
Hold
0
Sell
0
Price Target (9 analysts)
$10.60
Range $10.00 – $12.00
+106.8%
Consensus $10.60 vs current $5.13